Drägerwerk stock falls 1.52 percent as margins improve

Published on 10/04/2026 at 10:18 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Drägerwerk stock traded at EUR 117.00 on October 2, 2026, after a 1.52 percent decline. Second-quarter revenue rose 8.63 percent to EUR 847.31 million.

Schwarzweiß-Reportagefoto eines Feuerwehrmanns mit Atemschutzgerät im Einsatz — Drägerwerk AG & Co. KGaA Sicherheitstechnik Feuerwehrmann Atemschutz dramatischer Einsatz Rauchgebäude DE0005550636, Illustration mit AI erstellt.

Drägerwerk stock (ISIN DE0005550636) was last at EUR 117.00 on Xetra on October 2, 2026, down 1.52 percent from the previous close. The market is weighing a stronger earnings profile against an average analyst target of EUR 109.00.

Margins improve in Q2

Drägerwerk reported second-quarter revenue of EUR 847.31 million for the period ended June 30, 2026, up 8.63 percent from EUR 779.99 million a year earlier, while earnings per share increased to EUR 1.58 from EUR 0.61, according to finanzen.net on September 23, 2026.

The earnings improvement was also visible in profitability. In its Q2 2026 earnings call, Yahoo Finance reported that the quarterly EBIT margin rose to 5.4 percent from 2.6 percent in the comparable period.

Guidance sets the next test

Drägerwerk's investor-relations page lists 2026 currency-adjusted revenue growth guidance of 2 percent to 6 percent and an EBIT margin range of 5.0 percent to 7.5 percent. The same page now shows the current EBIT margin expectation at 6.0 percent to 8.0 percent, making margin delivery the central operating checkpoint for the second half.

The company operates in medical and safety technology, serving hospitals, emergency services, authorities, mining and industrial customers. Its 2025 revenue was EUR 3.5 billion, while the business employed 16,700 people across more than 190 countries, according to Dräger.

Analyst target stays above price

MWB Research raised its Drägerwerk price target from EUR 114 to EUR 130 in late August, as Finanztrends reported on September 8, 2026. The EUR 130 target lies 11.1 percent above the EUR 117.00 Xetra price, while the broader average target of EUR 109.00 sits below the latest market level.

The next scheduled operating milestone is the Q3 2026 earnings release on October 29, 2026, followed by an analyst and investor day on November 18, 2026, according to Marketscreener.

Stock remains below yearly high

At EUR 117.00, Drägerwerk stock was 6.7 percent below its 52-week high of EUR 125.40 on October 2, 2026. The reference quote had a day range of EUR 116.20 to EUR 119.00 and volume of 19,453 shares, with market capitalization at EUR 2.2 billion.